AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 39 filers reported holding AIM IMMUNOTECH INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,508 | +83322.2% | 16,501 | +126830.8% | 0.00% | – |
| Q2 2023 | $9 | +50.0% | 13 | 0.0% | 0.00% | – |
| Q1 2023 | $6 | -99.9% | 13 | -100.0% | 0.00% | – |
| Q4 2022 | $9,075 | +126.9% | 29,275 | +382.1% | 0.00% | – |
| Q3 2022 | $4,000 | 0.0% | 6,073 | +13.7% | 0.00% | – |
| Q2 2022 | $4,000 | – | 5,342 | +88933.3% | 0.00% | – |
| Q1 2022 | $0 | – | 6 | -40.0% | 0.00% | – |
| Q4 2021 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 10 | -41.2% | 0.00% | – |
| Q2 2021 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 17 | -32.0% | 0.00% | – |
| Q4 2019 | $0 | – | 25 | +25.0% | 0.00% | – |
| Q3 2019 | $0 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
| Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
| Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |